EverImmune launches phase I clinical trial for its oncobiotic drug candidate in lung and kidney canc
First patient to be administered Oncobax® AK, a live bacterial product based on a specific strain found in the gut microbiota, at Institut de Cancérologie Strasbourg Europe (ICANS) in Strasbourg, France60 patients across France and Belgium to take part in a trial which aims to assess the toxicity and efficacy of the...
Source: pharmiweb.com